Bernard Fabien Mandrand

GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France.

LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France.

CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

Swallis Medical SAS engages in the provision of diagnostic and monitoring solutions for problem of swallowing disorders. The company was founded by Linda Nicolini in 2019 and is headquartered in Toulouse, France.

TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France.

Backbone SAS is a venture capital and private equity firm. It specializes in investments in late venture companies, startups, buyouts, growth financing, leveraged buyouts, and buyins. The company was founded by Nazanine Sahami on March 25, 2015 and is headquartered in Le Bouscat, France.

MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France.

Sud Ouest Capital Risque Innovation SAS invests in innovative companies established in the Aquitaine and Midi-Pyrénées regions. The fund invests in the range of €150,000 - €1 million per transaction and also makes co-investments.

IRDInov SAS functions as an investment holding French company. The private company is based in Paris, France.

Ffly4u SASU provides a low frequency localization services for mobile assets. It also offers services like movement, temperature, noise or opening detection in order to guarantee the integrity of sensitive assets. The company was founded by Pages Olivier in 2015 and is headquartered in Toulouse, France.

FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France.

Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.

Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.

AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018.

Bouygues Telecom Initiatives SASU (BTI) is the corporate venture subsidiary of the mobile telecommunications company Bouygues Telecom SA, which is majority-owned by the diversified French group Bouygues SA (XP: EN), active in sectors including construction, road infrastructure, real estate development, media and telecommunications. BTI was established in 2008 and is located in Meudon. The firm has a strategic alliance with the Microsoft start-up support program IDEAS. Their fellow subsidiary e-lab Bouygues SA is the corporate research and development specialist for the Bouygues group, and focuses on strongly innovative startups primarily outside of the telecommunications sector.

EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

Société Coopérative Agricole Interface Céréales SCA engages in the development of sustainable agriculture. It provides animal feeds, fertilizers, agricultural chemicals, and other farm supplies. The company was founded in December 2005 and is headquartered in Dreux, France.

Cryolog SA provides traceability software solutions. The company was founded by Renaud Vaillant in 2002 and is headquartered in Nantes, France.

Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France.

LDL Technology SAS designs, manufactures and develops wireless embedded electronic systems. Its technologies include tire pressure monitoring systems, vehicle immobilization, keyless entry and start system, and body control units. The company was founded by Dominique Luce and Philippe Lefaure on June 30, 2004 and is headquartered in Ramonville-Saint-Agne, France.

UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France.

Guard Medical, Inc. creates products that aim to improve the quality of life for surgical patients. The company is based in Miami, FL and was founded by Machiel van der Leest, J. Frederick Cornhill, Laurence Lefebvre, Sang Lee. The company is behind NPseal, a negative pressure wound therapy dressing that is easy to use and does not require batteries or tubes. The dressing features a simple pinch pump that applies and maintains gentle negative pressure that may promote wound healing. Numerous peer-reviewed studies have demonstrated the utility of NPWT in reducing wound healing time.

IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse.

IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks.

PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France.